We are live on ! Find out more
NBP icon

NovaBridge Biosciences American Depositary Shares

28 hedge funds and large institutions have $10.1M invested in NovaBridge Biosciences American Depositary Shares in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 28 → 28 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

3.68% less ownership

Funds ownership: 18.3% → 14.62% (-3.7%)

40% less capital inflows, than outflows

Capital inflows: $4.94M | Capital outflows: $8.19M

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $12K

Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
3
Reduced
6
Closed
7
Calls
–
Puts
$12​K
Net Calls
-⁠$12​K
Net Calls Change
-⁠$75​K

NBP Hedge Fund Activity: Q4 2024 in Review

28 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2024, worth a combined $10.1M — down 42% from $17.6M a quarter earlier.

Fund positioning in NBP was balanced in Q4 2024: 7 funds opened new positions, 7 closed out, 3 added to existing stakes and 6 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $3.91M. The largest seller was Caligan Partners, exiting entirely with an estimated $4.34M sold.

  • 28 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $10.1M of NovaBridge Biosciences American Depositary Shares stock for Q4 2024, down 42% quarter-over-quarter.
  • 7 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2024 and 7 closed out, a net change of 0 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2024 was Morgan Stanley, an estimated $3.91M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2024 was Caligan Partners, an estimated $4.34M sold.

Based on aggregated 13F filings for Q4 2024.